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The main otorhinolaryngological manifestations of CF 
are chronic rhinosinusitis and nasal polyposis, with different 
clinical presentations. Aim: To characterize children and 
adolescents with cystic fibrosis through a questionnaire, 
an ENT clinical examination and nasal endoscopy. Study 
design: Cross-sectional clinical descriptive. Material and 
Method: Assessment of 100 children and adolescents with 
cystic fibrosis through a specific questionnaire, ENT physical 
examination, nasal endoscopy and endoscopic staging of 
nasal polyps. Results: The most frequent symptoms were: 
cough (45%), oral breathing (44%), sleep disorders (42%) 
and nasal obstruction (37%). Twenty-eight patients (28%) 
had purulent nasal discharge, and 41% had medial bulging 
of the nasal lateral wall. Nasal polyps were identified in 
only 14% of cases, none were obstructing. Conclusion: 
The questionnaire, clinical examination and especially 
nasal endoscopy lead to a detailed assessment of the nasal 
characteristics of children and adolescents with cystic fibrosis. 
Some findings were discordant with the literature, particularly 
the low prevalence of nasal polyps, and appear to be related 
to specific characteristics of the population studied. The 
best characterization of this group of patients, from the ENT 
standpoint, contributes to an appropriate multidisciplinary 
approach.
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INTRODUCTION
Cystic fibrosis (CF) is the most common inherited 
autosomal recessive disorder in Caucasians.1-6 Its pre-
valence ranges from 1:6.000 to 1:2.000 of live births in 
white populations of developed countries;1,3,4,6-9 it is rare 
in black (1:30.000) and Asian (1:90.000)10,11 populations. 
In Brazil, the incidence ranges from 1:9.500 in Parana 
state,12 to 1:8.700 in Santa Catarina state,13 and 1:10.000 
in Minas Gerais state.14
This disease results from mutations in the cystic 
fibrosis transmembrane conductance regulator gene 
(CFTR), located on the q31 region of the long arm of 
chromosome 7.15-17 This gene, which was described in 
1989,15-17 encodes for a protein that functions as a chlori-
de channel; dysfunction of this channel results in altered 
sodium, chloride and water transport across the apical 
membrane of epithelial cells in the respiratory tract and 
in exocrine glands. Altered salt and water flow result in 
loss of hydration of exocrine gland fluids and altered 
viscoelasticity of mucins.5,6,18,19
Most patients with CF (over 90%)3,6,18,20-25 develop 
chronic and recurring rhinosinusitis, with or without nasal 
polyps. Altered mucus composition and viscoelasticity 
results in decreased mucociliary clearance and obstruc-
tion of paranasal sinus drainage ostia, facilitating local 
inflammation, hypoxia and increased carbon dioxide 
partial pressure. Mucosal edema ensues, compromising 
ciliary function and favoring bacterial colonization, usually 
by Staphylococcus aureus and Pseudomonas aerugino-
sa.3,6,18,26
Nasal polyposis in CF patients were first described 
in 1959;27 to date, little is known about its pathophy-
siology.28-30 The frequency of nasal polyposis varies in 
different populations, and depends on the evaluation 
technique.26,29,31-42
It is thought that nasosinusal involvement may 
worsen pulmonary manifestations;20 thus, otorhinola-
ryngologists have become more involved in evaluating 
these patients. Recent studies in Brazil26,40,41 have shown 
a growing concern with characterizing in more detail the 
nasosinusal findings of CF patients, because this disorder 
is genetically very heterogeneous, with many types of 
mutations and a wide variety of clinical presentations,28 
which may be explained by specific phenotypic features 
of the Brazilian population and even within populations 
of any given region in this country.
The aim of this study was to characterize the na-
sosinusal findings in child and adolescent patients with 
CF in the state of Minas Gerais, using a questionnaire 
(clinical history), the physical examination, and nasal 
endoscopy nasal.
MATERIALS AND METHODS
The Institutional Review Board of our institution 
evaluated and accepted the research design and the free 
informed consent form (protocol number: 177/2002). All 
patients and/or their caretakers agreed to participate and 
signed the free informed consent form.
We conducted a cross-sectional descriptive cli-
nical study consisting of a guided clinical history, a full 
otorhinolaryngological physical examination, and nasal 
endoscopy of 100 patients aged from 7 months to 18 
years, with a diagnosis of CF and varying degrees of res-
piratory involvement. All participants had clinical findings 
compatible with and a diagnosis of CF, confirmed by the 
sweat test (Gibson and Cooke method43) according to the 
guidelines of the Cystic Fibrosis Foundation.8
Patients were seen in the Pediatric Pneumology and 
Otorhinolaryngology Units of the hospital from July 2002 
to January 2004. Hospitalized patients with a diagnosis of 
active upper airway infection, using systemic antibiotics 
or topical nasal corticosteroids, were assessed three to 
six months later, when these exclusion criteria were no 
longer present.
Nasal endoscopy was done with a flexible 3.2 mm 
diameter endoscope (Machida Endoscopy Co., Japan) after 
topical nasal anesthesia with neutocaine; in some cases, 
rigid endoscopy was done with a 4 mm diameter 00 angle 
endoscope (Fiegert Endotech, Germany).
Nasal polyps were staged according to Lund and 
Kennedy’s44 endoscopic staging criteria, which evaluated 
the following parameters: nasal mucosa edema, presen-
ce of discharge, and presence of polyps. Each of these 
parameters were assessed bilaterally and scored from 0 
to 2, as shown on Frame 1. The total score (0 - 12) is the 
sum of scores of each side.
Statistics consisted of a descriptive analysis, con-
fidence intervals (calculated using the EpiInfo 2004 sof-
Frame 1. Endoscopy scores in the Lund-Kennedy method.
Features Right nasal cavity Left nasal cavity
Polyp (0, 1, 2)   
Edema (0, 1, 2)   
Discharge (0, 1, 2)   
Total   
Notes:
Polyps: 0 - absent, 1 - restricted to MM, 2 - extending to the nasal 
cavity
Edema of mucosa: 0 - absent, 1 - mild/moderate edema, 2 - polypoid 
degeneration
Discharge: 0 - absent, 1 - hyaline, 2 - thickened and/or mucopurulent
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tware), a comparison of means by the Kruskal-Wallis test, 
and parametric tests (“t” test and analysis of variance or 
ANOVA). Means were considered as statistically significant 
when the p value (“t” test, ANOVA, and the Kruskal-Wallis 
test) was below 0.05 (or 5%).
RESULTS
The study sample comprised 61% of male patients 
with ages ranging from seven months to 18 years (mean: 
8.4 years); 50% were aged below eight years, and 75% 
were aged below 11 years. Most of the patients (59%) were 
brown-colored; there were no black or Asian patients.
The most frequently reported (by patients and/or 
caretakers) upper airway complaints were coughing, pre-
dominant mouth breathing, sleep disorders (characterized 
as agitated sleep, snoring, and repeated awakenings), na-
sal block, halitosis, headaches, and rhinorrhea, as shown 
on Table 1. None of these symptoms were present in 21% 
of patients at the time of the evaluation.
The physical examination and endoscopy revealed 
that 36% of patients had a normal middle meatus (MM) 
bilaterally. The sphenoethmoidal recess (REE) could not 
be evaluated in most patients (51% to the right and 58% 
to the left) since this structure is undeveloped in children 
and hard to evaluate in the presence of septal deviations, 
polyps, or medial bulging of the lateral wall of the nose. 
Thirty patients had bilaterally normal REEs. Medial bulging 
of the lateral wall of the nose was found in 41 patients 
(bilateral in 36 of these patients). Patients in which the 
auditory tube ostia were not seen had adenoid hyperpla-
sia, which caused obstruction (Table 2).
There was no statistically significant association (p 
= 0.68) between age and the presence of medial bulging 
of the lateral wall of the nose.
Nasal endoscopy revealed mucoid discharges in 
58% of patients, particularly on the floor of nose; mu-
copurulent discharges were found in 28% of patients 
(25% in the MM). There was an association between the 
presence of nasal discharges on endoscopy and reports 
of rhinorrhea (p = 0.05), as expected. The presence of 
nasal discharge was more common in patients aged from 
6 to 18 years compared to patients aged 5 years or less.
Endoscopy revealed nasal polyps in fourteen pa-
tients (14%), of which five had bilateral polyps (35.7%). 
There was no statistically significant difference in the side 
of the nose where polyps were found (p = 1.0) or in the 
presence of mucopurulent discharges (p = 0.67). Table 3 
shows the statistically significant association between nasal 
polyps and mucopurulent discharges (p = 0.02) and be-
tween nasal polyps and discharges of any kind (p = 0.02).
There were no associations between sex or age and 
nasal polyps (p = 0.07), as seen on Table 3. However, 50% 
of nasal polyp cases were diagnosed in children aged 6 
years or less, and no polyps were found in patients aged 
16 years or above. Of 14 patients with polyps, 9 (64.3%) 
were aged between 4 and 12 years.
No patient presented obstructing polyps. The 
Lund-Kennedy staging44 of 14 patients with nasal polyps 
is shown on Chart 1 (mucosal edema, nasal discharge, 
and presence and size of polyps, bilaterally.
Table 1. Distribution of symptoms in the sample of patients.
Variables % IC 95%
Coughing 45,0 34,5 - 54,8
Mouth breathing 44,0 33,5 - 53,8
Sleep disorders 42,0 31,6 - 51,8
Nasal obstruction 37,0 26,9 - 46,6
Halitosis 33,0 23,3 - 42,5
Headache 30,0 20,6 - 39,3
Rinorrhea 29,0 20,6 - 39,5
Dysphonia 20,0 12,8 - 29,5
Intolerance for physical activity 16,0 9,5 - 24,9
Daytime drowsiness 16,0 8,7 - 23,8
Periorbitary pain 11,0 5,0 - 17,8
Facial pain 10,0 4,2 - 16,6
Anosmia 2,0 0,2 - 7,1
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Table 3. Comparison of the presence of polyps, symptoms, sex and age.
 Nasal polyps
 Yes No
Valor-p OR IC 95%
 N % N %
Mucopurulent discharge
Yes 8 28,6 20 71,4 0,02* 4,40 1,18-16,77
No 6 8,3 66 91,7 1,0
Mucoid discharge
Yes 12 17,9 55 82,1 0,13* 3,38 0,64-23,78
No 2 6,1 31 93,9 1,0
Any discharge
Yes 14 18,7 61 81,3 0,02* ...
No 0 0,0 25 100,0 1,0
Sex
Male 5 8,2 56 91,8 0,07 0,3 0,08-1,10
Female 9 23,1 30 76,9
Age
< 6 years 6 22,7 21 77,8 1,0
6 - 11 years 6 12,2 43 87,8 0,33* 0,49 0,12-1,99
≥ 12 years 2 8,3 22 91,7 0,25* 0,32 0,04-2,07
* Fisher test
Table 2. Distribution of nasal endoscopic findings.
Variables
Nasal cavity (%)
Right Left Bilateral
Nasal mucosa
Congestion 57,0 54,0 24,0
Hyperemia 10,0 10,0 9,0
Mucoid discharge
Floor of nose 44,0 48,0 20,0
Middle meatus 33,0 28,0 15,0
Sphenoethmoidal recess 1,0 1,0 0,0
Mucopurulent discharge
Floor of nose 12,0 14,0 10,0
Middle meatus 17,0 21,0 13,0
Sphenoethmoidal recess 3,0 3,0 1,0
Other findings
Nasal polyps 10,0 9,0 5,0
Medial bulging of lateral wall 41,0 36,0 36,0
Free auditory tube ostium 86,0 83,0 79,0
Nasal septal deviation ... ... 19,0
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DISCUSSION
Most of the papers cited below are by European 
and North American authors; some have studied both 
children and adults with CF. They thus reflect a different 
population to that of our study. There are few published 
studies on the features of CF populations in developing 
countries, many of which have smaller samples compared 
to our study.
 
Clinical findings
The most frequently reported symptoms in chil-
dren and adolescents with CF reported in our study were 
coughing, the most frequent symptom (45%), mouth 
breathing (44%), agitated sleep (42%), nasal block (37%), 
halitosis (33%), headaches (30%), and rhinorrhea (29%). 
Mouth breathing and sleep disorders are closely related 
with nasal block.15 Two patients only reported anosmia, 
and about 10% reported periorbitary or facial pain. The 
reported frequency of these symptoms in CF patients is 
very variable in the literature, although generally higher 
than the frequency in our study. Recent European and 
North American studies have shown that the symptoms 
most frequently associated with CF are coughing (in about 
60%),29 nasal block (in 60 to 90.5%),3,29,45,46 rhinorrhea (in 
20 to 85.7%),3,29,36,45,46 headaches (in 22.6 to 71.4%),3,29,46 
facial pain (in 15 to 57.1%),45,46 and sleep disorders 
with agitation, snoring and daytime drowsiness (in 37%), 
especially in patients with severe nasal block.15 In Brazil, 
Boari and Castro Jr.42 found that except for coughing, 
symptoms of rhinosinusitis occurred infrequently. These 
variations probably reflect the small samples and different 
age groups in these studies.
An important point is that although some studies 
have shown that up to 100% of CF patients had pansi-
nusopathy evidenced on facial sinus computed tomo-
graphy,3,6,18,20-25 20% of these patients complained of no 
symptoms, and 36% had no alterations in the middle 
meati bilaterally. Other studies have also shown a lack 
of correlation between tomographic findings and clinical 
manifestations. Moss and King47 found that a relatively 
low rate of nasal complaints occurs because patients or 
caretakers pay more attention to the severe findings of 
the disease; patients appear to “adapt” to chronic nasal 
symptoms and lack knowledge about or underestimate 
how much nasosinusal manifestations may affect the 
progression of respiratory conditions.
 
Nasal endoscopy
There is a wide variety of endoscopic findings in 
patients with CF, and a tendency for more diagnoses of 
nasal polyps as we move forward in time. From 1961 to 
2005, the prevalence of nasal polyps increased from 5 to 
57%.26,29,31-38,40-42 Explanations include increased survival 
rates of CF patients in developed countries, the selection 
of patients, sample sizes, different age groups in these 
studies, and especially the more recent routine use of 
nasal endoscopy as a diagnostic tool.3,19,48 Brihaye et al.29 
showed that over 25% of polyps were not diagnosed in 
the clinical examination with anterior rhinoscopy without 
nasal endoscopy in CF patients. Only nasal endoscopy 
can provide an adequate view of the middle meatus and 
the posterior half of the nose.4,21,49 Boari and Castro Jr42 
compared clinical, tomographic and endoscopic findings 
and found that nasal endoscopy helped significantly in 
evaluating chronic rhinosinusitis and nasal polyps in CF 
patients; endoscopy accurately characterized the nasosi-
nusal status.
Nasal polyps were found in only 14% of children 
and adolescents with CF in our study, although our as-
sessment method was similar to that in recently published 
papers. Studies of children and adolescents only have 
shown varying frequencies of nasal polyps: 22.2% of 27 
CF patients by Denoyelle et al.36 in France, 57% of 23 
CF patients by Yung et al.19 in England, and 32.6% of 89 
patients by Cimmino et al.6 in Italy. Schmitt et al.41 retros-
pectively evaluated the medical files of 893 children with 
CF - the largest sample of this disorder in the literature 
- and found nasal polyps in only 5% of subjects.
Brazilian studies have also shown a significant va-
riation in the diagnostic frequency of nasal polyps in CF 
patients. Weber and Ferrari40 found nasal polyps in 39.1% 
of CF patients in a sample of 23 patients aged from one 
year and nine months to 22 years and 8 months. Boari 
and Castro Jr.42 used nasal endoscopy and found polyps 
in only three (8.82%) of 34 CF patients aged from six to 22 
years. Sakano et al.26 used rigid endoscopy under general 
anesthesia and found nasal polyps in 36% of 50 patients 
aged over 2 years; this method may have increased the 
diagnostic accuracy for polyps, including very small ones. 
These three studies evaluated children within the same 
geographical area (state of Sao Paulo).
Chart 1. Endoscopic staging (Lund-Kennedy) of 14 patients with 
nasal polyps.
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Given the ample genetic heterogeneity of CF, with 
many mutations and a variety of clinical presentations,28 a 
low prevalence of nasal polyposis in our study compared 
to studies in developed countries may be explained by 
the specific genotypic features of each sample popula-
tion. One may also suspect that CF is underdiagnosed in 
Brazil, and that early death of patients with respiratory 
complications - possibly with nasal polyps - may occur, 
given that in this country the mean survival age of CF 
patients is lower than that in developed countries, where 
it may reach 31.6 years.6,50 A recent Brazilian study by 
Alvarez et al.51 revealed that the mean survival of 104 CF 
patients in that study was 18 years and four months after 
the diagnosis.
Our results shown that all patients with nasal polyps 
also had nasal discharges, although there was no relation 
between the presence of nasal polyps and symptoms 
such as coughing, rhinorrhea, mouth breathing, agitated 
sleep, headaches, and nasal block, even though certain 
authors1,3,24,28 have described nasal block as a typical 
symptom in CF patients with nasal polyps. Gentile and 
Isaacson28 compared 19 CF patients aged from six to 25 
years, with and with no nasal polyps, and found that the 
most frequent complaint in patients with polyposis was 
nasal block. Henriksson et al.5 also found no differences 
among patients with and with no nasal polyps concerning 
symptoms such as rhinorrhea, nasal block, and mouth 
breathing. Kennedy and Loury52 had found no parallel be-
tween nasal symptoms and the occurrence of nasal polyps.
In the present study we found no statistically 
significant association between nasal polyps and age; 
however, 64.3% of patients with polyps were aged from 
4 to 12 years, concurring with Jaffe et al.’s53 and Sakano 
et al.’s26 reports (88.89% of cases of nasal polyps in pa-
tients below age 15 years). On the other hand, Brihaye 
et al.3 reported that the prevalence of polyps in younger 
children was significant, since (50%) of 14 children and 
adolescents with nasal polyps were aged six years or less; 
the youngest child with a nasal polyp was aged eight 
months, with the differential diagnosis being made by 
computed tomography of the nose and facial sinuses. No 
other author has described nasal polyps in CF patients 
aged below one year and four months.
It is thought that medial bulging of the lateral wall 
of the nose results from intraluminal pressure exerted by 
polyps and/or viscous secretions retained in the paranasal 
sinuses, especially in younger children in which the late-
ral wall is more elastic than in adults.3,21 Medial bulging 
of the lateral wall of the nose was found in 41% of our 
sample, which concurs with other published results (12 to 
76%).3,29,46 However, there was no statistically significant 
relation between medial bulging of the lateral wall of the 
nose and the age of patients in this study.
Endoscopic staging of nasosinusal polyps
Endoscopic staging of nasal polyps is required to 
quantify disease severity and to assess the response to the-
rapy. It is also possible to compare data with that of other 
authors, thus characterizing different groups of patients 
with nasal polyps. There is, however, consensus around 
a single and uniform staging method in the literature.44
Several authors, applying different staging methods, 
have reported variable prevalence rates of obliterating 
polyposis. A few studies reported the presence of many 
polyps in up to 70% of cases, while other studies found 
no CF patient with obstructing polyps.3,5,6,19,29
None of the 14 children with nasal polyps in our 
sample had obliterating polyps. Ten patients had nasal 
polyps to the right and 9 patients had polyps to the left. 
The maximum score, in the Lund-Kennedy44 staging 
method, was 10 and the minimum score was 2, which 
demonstrates the variable nature of nasal endoscopic 
findings in CF patients with nasal polyps.
Our findings show that the clinical and endosco-
pic nasal findings in 100 children and adolescents were 
in part different from those of CF patients in developed 
countries and in different regions of Brazil. There is a 
paucity of such information in Latin-American countries, 
and efforts should be made to increase our understan-
ding of the specificities of our CF populations, to guide 
specific therapy and early public health measures based 
not only on international data. Future studies involving all 
major centers treating CF in Brazil with standard methods 
would be of great value in a multidisciplinary approach 
to these patients.
CONCLUSION
This study led to the following conclusions in the 
sample population:
• the main otorhinolaryngological manifestations 
were coughing, mouth breathing, disordered sleep, nasal 
block, halitosis, headaches, and rhinorrhea; these findings 
were generally found at a lower proportion compared to 
other studies of patients with CF;
• nasal polyps were present in only 14% of pa-
tients; there were no cases of obstructing polyps; there 
was a significant association between the presence of 
nasal polyps and nasal discharge, but not between nasal 
polyps and age, or nasal polyps and symptoms such as 
nasal block, coughing and headaches;
• medial bulging of the lateral wall of the nose was 
seen endoscopically in a significant number of patients 
(41%);
• nasal endoscopy was carried out successfully in 
all 100 patients; it was performed with no difficulty and 
was deemed essential in the evaluation of the nose and 
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sinus cavities of patients with CF, especially in patients 
with respiratory manifestations with no accurate diagnosis 
or difficult to control clinically, regardless of age.
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